11/21
08:07 am
biib
Rating for BIIB
Low
Report
Rating for BIIB
11/21
08:07 am
biib
Rating for BIIB
Low
Report
Rating for BIIB
11/18
07:21 am
biib
Biogen Inc. (NASDAQ: BIIB) was downgraded by analysts at Needham & Company LLC to a "hold" rating. They now have a $270.00 price target on the stock.
Low
Report
Biogen Inc. (NASDAQ: BIIB) was downgraded by analysts at Needham & Company LLC to a "hold" rating. They now have a $270.00 price target on the stock.
11/18
05:07 am
biib
Rating for BIIB
Low
Report
Rating for BIIB
11/18
05:07 am
biib
Rating for BIIB
Low
Report
Rating for BIIB
11/15
08:04 am
biib
Biogen Inc. (NASDAQ: BIIB) is now covered by analysts at Wolfe Research. They set a "peer perform" rating on the stock.
Medium
Report
Biogen Inc. (NASDAQ: BIIB) is now covered by analysts at Wolfe Research. They set a "peer perform" rating on the stock.
11/15
08:04 am
biib
Biogen Inc. (NASDAQ: BIIB) is now covered by analysts at Wolfe Research. They set a "peer perform" rating on the stock.
Medium
Report
Biogen Inc. (NASDAQ: BIIB) is now covered by analysts at Wolfe Research. They set a "peer perform" rating on the stock.
11/15
07:17 am
biib
Rating for BIIB
Medium
Report
Rating for BIIB
11/15
07:17 am
biib
Rating for BIIB
Medium
Report
Rating for BIIB
11/15
05:59 am
biib
Biogen Inc. (NASDAQ: BIIB) was upgraded by analysts at Citigroup Inc. to a "hold" rating.
Medium
Report
Biogen Inc. (NASDAQ: BIIB) was upgraded by analysts at Citigroup Inc. to a "hold" rating.
11/15
05:13 am
biib
Rating for BIIB
Medium
Report
Rating for BIIB
11/15
05:13 am
biib
Rating for BIIB
Medium
Report
Rating for BIIB
11/14
04:08 pm
biib
Biogen initiated with neutral view at Wolfe Research
Low
Report
Biogen initiated with neutral view at Wolfe Research
11/14
04:08 pm
biib
Biogen initiated with neutral view at Wolfe Research
Low
Report
Biogen initiated with neutral view at Wolfe Research
11/14
07:53 am
biib
Rating for BIIB
Low
Report
Rating for BIIB
11/14
07:53 am
biib
Rating for BIIB
Low
Report
Rating for BIIB
11/14
07:35 am
biib
Biogen Inc. (NASDAQ: BIIB) is now covered by analysts at Citigroup Inc.. They set a "neutral" rating and a $190.00 price target on the stock.
Low
Report
Biogen Inc. (NASDAQ: BIIB) is now covered by analysts at Citigroup Inc.. They set a "neutral" rating and a $190.00 price target on the stock.
11/4
09:36 am
biib
Rating for BIIB
Low
Report
Rating for BIIB
10/31
02:09 pm
biib
Rating for BIIB
Low
Report
Rating for BIIB
10/31
02:09 pm
biib
Rating for BIIB
Low
Report
Rating for BIIB
10/31
02:00 pm
biib
Rating for BIIB
Low
Report
Rating for BIIB
10/31
02:00 pm
biib
Rating for BIIB
Low
Report
Rating for BIIB
10/31
10:42 am
biib
Biogen Inc. (NASDAQ: BIIB) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $300.00 price target on the stock.
Low
Report
Biogen Inc. (NASDAQ: BIIB) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $300.00 price target on the stock.
10/31
07:36 am
biib
Biogen Inc. (NASDAQ: BIIB) was downgraded by analysts at Morgan Stanley from an "overweight" rating to an "equal weight" rating. They now have a $204.00 price target on the stock, down previously from $285.00.
Low
Report
Biogen Inc. (NASDAQ: BIIB) was downgraded by analysts at Morgan Stanley from an "overweight" rating to an "equal weight" rating. They now have a $204.00 price target on the stock, down previously from $285.00.
10/31
07:36 am
biib
Biogen Inc. (NASDAQ: BIIB) was downgraded by analysts at Morgan Stanley from an "overweight" rating to an "equal weight" rating. They now have a $204.00 price target on the stock, down previously from $285.00.
Low
Report
Biogen Inc. (NASDAQ: BIIB) was downgraded by analysts at Morgan Stanley from an "overweight" rating to an "equal weight" rating. They now have a $204.00 price target on the stock, down previously from $285.00.